COVID-19 Impact on Global Mefenamic Acid Market

  • On January 30, 2020, the International Health Regulations Emergency Committee of the World Health Organization (WHO) declared the Coronavirus disease (COVID-19) outbreak a public health emergency of international concern. Originating in China, the virus has spread to at least 214 countries and territories around the world.
  • Several governments and private sector businesses are operating at a limited capacity or have ceased operations completely due to recent events surrounding the COVID-19 pandemic
  • The outbreak of the COVID-19 pandemic has led to disturbance in the supply chain due to the global lockdown in several countries. The spread of coronavirus has led to a fall in demand for chemical intermediates due to uncertainty in the global economy and capital markets.
  • Growth of the mefenamic acid market has been hampered due to the COVID-19 pandemic and lockdown of several non-essential activities and manufacturing facilities in most countries. However, the market is anticipated to expand at a healthy pace during the forecast period due to the acceptance of new normal conditions and recovery of various end-use industries in many countries.

Key Drivers and Restraints of Mefenamic Acid Market

  • Demand for mefenamic acid is expected to increase at a significant pace during the forecast period due to the increase in prevalence of dysmenorrhea, and rise in level of awareness and growth in concern about dysmenorrhea among women in developed countries. Most women tend to have dysmenorrhea during puberty, typically within four to five years of the first menstrual cycle. Prostaglandins are chemicals produced in the lining of the uterus during menstruation. These prostaglandins trigger muscle contractions in the uterus, which cause discomfort and reduce the flow of blood and oxygen to the uterus. Mefenamic acid helps reduce menstrual pain.
  • The side effects of mefenamic acid are negatively affecting the mefenamic acid market. Mefenamic acid causes side effects including nausea, tiredness, itching, upper stomach pain, flu-like symptoms (fever, chills, body aches), severe skin redness, itching, and peeling.

Mefenamic Acid Market: Application Segment

  • Based on application, the global mefenamic acid market can be divided into hospitals, drug stores, and others
  • The hospital segment dominates the mefenamic acid market
  • Mefenamic acid is available in the form of capsule. Mefenamic acid capsules are a member of the fenamates group of nonsteroidal anti-inflammatory drugs (NSAIDs).
  • In hospitals, it is used to treat mild to moderate pain and dysmenorrhea

North America to Hold Leading Share of Global Mefenamic Acid Market

  • In terms of region, the mefenamic acid market can be divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • North America is expected to hold major share of the global mefenamic acid market, followed by Asia Pacific and Europe, during the forecast period
  • As per a study published in the Indian Journal of Research, about US$ 2 Bn or 600 million working hours are lost annually in the U.S. due to incapacitating dysmenorrhea. Furthermore, women who attend classes or work have been shown to have lower work output or scores during their dysmenorrhea. Increase in research and development for innovative drugs and the presence of well-established health care infrastructure in the U.S. are fuelling the market in North America.

Key Manufacturers Operating in Global Mefenamic Acid Market

The mefenamic acid market was consolidated in 2020. Major players have prominent presence in developed and developing countries. Key manufacturers operating in the mefenamic acid market include:

  • Shionogi Pharma
  • Solitaire Pharmacia
  • Shinto Organics
  • Captab
  • EMS Pharma
  • Adelco
  • Agron Remedies
  • IASIS Pharmaceuticals Hellas
  • ABL Lifecare
  • Farmo Quimica
  • Apotex
  • Sanofi Aventis
  • Yung Sine
  • Streuli Pharma,
  • Mankind
  • Pfizer
  • Daiichi Sankyo
  • Koa Isei
  • Teva
  • Wockhardt
  • Esteve

Mefenamic Acid Market: Research Scope

Mefenamic Acid Market, by Type

  • Patent
  • Generic

Mefenamic Acid Market, by Application

  • Hospitals
  • Drug Stores
  • Others

Global Mefenamic Acid Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia & CIS
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • ASEAN
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Mefenamic Acid Market: Introduction

  • Mefenamic acid is a nonsteroidal anti-inflammatory drug (NSAID). It belongs to a class of drugs called beta-blockers. Systematic name of mefenamic acid is dimethylphenylaminobenzoic acid.
  • Mefenamic acid works by reducing hormones that cause inflammation and pain in the body.
  • It is used short-term (seven days or less) to treat mild to moderate pain in adults, and children who are at least 14 years old. Mefenamic acid is also used to treat menstrual pain.
  • Mefenamic acid is a prescription medicine used to treat symptoms of high blood pressure (hypertension). It may be used alone or with other medications.

This upcoming business intelligence report is intended to be a one-stop market research solution to guide organizations in taking timely and effective decisions for their business growth. The ongoing study is the culmination of our deep expertise on data science methods, combined with an unparalleled understanding of the external environment and analysis of the industries. Each of the reports by TMR aims at offering a detailed scrutiny of the value chain of our current and prospective customers, takes them from identifying value propositions, and subsequently assist their business executives to implement right strategies to create customer value. We believe that creating and sustaining the customer value is the key pivot on which business executives can create profits for their organizations and increase the market shares, continuously and with sustainability.

Each of our touchpoints through which we engage with the organization/enterprise during the primary research enables us to understand the internal environment it operates in and the ways in which the external environment influences its growth.

Always Evolving with Competition

Excellence is built into the DNA of TMR, and all our teams work collaboratively and committedly toward achieving that in whatever they do. From the very first interaction our teams of research analysts have with any interested market participant to the final preparation processes in each of our reports reflects a rigorous understanding of the dynamic industry environment that businesses operate in.

We relentlessly work to be a differentiator in whatever we do in the current era of hypercompetitive global environment. The result of our unceasing focus on excellence is reflected clearly in the insights and guidance we offer to our customers in order to empower them to create brand equity. Our simple yet very powerful underpinning for navigating the competition is to always keep evolving with changing business environments. Our close-kinit team of research analysts not only believe in this simple philosophy but also implement the same.

Constantly Innovating Our Research Methodologies and Models

We do not limit with any specific market research tool or one standard approach for obtaining or analyzing data. Undoubtedly, our report making process is ever-evolving to meet the customer needs and demands supported broadly by a vast knowledge of data science methods that we combine with business acumen our teams have built upon for several years. Evidently, our primary and secondary research data about customers and consumers have shown that we can go to any lengths to obtain them. This is followed by applying next-gen automation tools integrated with human judgement to clear the clutter, ascertain the most relevant and recent qualitative and quantitative insights, and package them in digestible chunks in our reports for our customers.

We Take Pride in No-One-Size-Fits-All Approach

Over the past several years, we have been conducting market intelligence studies across all industries for all types of organizations — big and small, profit and not-for-profit, and Fortune 500 and Unicorns, as we believe that a sound decision making must be based on no-one-size-fits-all approach. Without doubt, each of the organizations regardless of the industry they are in are affected differently by changes in political, economic, socio-culture, legal, ecological, and legal environments. The research models and the value chain analysis process that our analysts employ for conducting the study uphold this approach.

We look at myriad components of internal and external business environment affecting the growth strategies of organizations. Some of the broader aspects that we focus on are:

  • Our team of Analysts and Support Teams always strive to see the bigger picture in life cycle stages of any industry
  • The Teams focus on obtaining valuable insights into different models of competitive advantage while making an internal environment analysis
  • They keep on modifying the value chain analysis processes of organizations to understand on how customer value is created

Some areas of assessing market dynamics that are used in the research models and methodologies adopted by our analysts can be summarized as:

  • Corporate and business strategies underlying new brand positioning strategies
  • Mapping for strategic planning for business units
  • Various metrics for business portfolio analysis, including BCG matrix
  • Value chain analysis

These will help create and sustain competitive advantage for our prospects and current customers.

Key focus areas and agenda that underpin and catalyze our primary and secondary research initiatives and endeavors are:

  • What are some of the core competencies and distinctive competencies of new entrants and established players in the industry we are analyzing?
  • What are some of the branding opportunities that are emerging at a rapid pace?
  • What are the major competitive forces and elements of external environment shaping the industry life cycle stages of most organizations?
  • Why some competitive strategies are popular than others among leaders in a certain market?
  • What customer-based brand equity strategies companies have leveraged in a certain industry or set of related industries in a sector?
  • What are some of the key pricing strategies that companies in an industry are implementing for marketing their products internationally?
  • Identifying whether market-push or market-pull strategies are more relevant to a certain product or a service?

Disclaimer: This ongoing market research study is a meticulously planned activity where a broad array of factors and aspects that shape the marketing environment and industry are taken into account. However, keeping in mind the constantly changing nature of business dynamics and changing strategic intents, we are always actively making iterations and modifications in our approaches. As always, we are ready to tailor our insights and guidance to suit your requirements. Engage with us to know what more is there for your CXOs.

Enquiry Before Buying

TMR offers Enquiry Before Buying that help clients to get information on their business scenario required where syndicated solutions are not enough.

Enquiry Before Buying

Mefenamic Acid Market